Filing Flows › Rapid Micro Biosystems (RPID) › Q1 2026
Rapid Micro Biosystems (RPID) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 15, 2026
Rapid Micro Biosystems (RPID) reported revenue of $8.0M for the first quarter 2026 (Q1 2026), +11% from a year earlier and -29% from the quarter before. Operating margin was -173.1%, net loss $14.3M (178.4% of revenue).
Rapid Micro Biosystems, Q1 2026: revenue $8.0M (+11% year over year), operating margin -173.1%, net loss $14.3M, operating cash flow −$15.1M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.0M | -29% | +11% |
| Operating profit | −$13.9M | — | — |
| Net earnings | −$14.3M | — | — |
| Operating cash flow | −$15.1M | — | — |
What changed
Revenue was $8.0M in Q1 2026, up 11% year over year and down 29% from the previous quarter. Product was the largest line at 70% of revenue. Product added $1.5M year over year (up 36%), 185% of the total change. Service declined 22%.
Gross margin was 4.6%, down 1.0 points from Q1 2025. Operating costs exceeded revenue by $13.9M, an operating margin of -173.1%. Operating expenses grew 18% against revenue growth of 11%. The fastest-growing cost line was General & admin (+31%). The quarter ended with a net loss of $14.3M, wider than the previous quarter's $12.5M loss.
Operating cash flow was −$15.1M. Non-cash charges added back $706K of depreciation and amortization and $1.2M of share-based compensation. Working capital and other items used $2.7M. Capital expenditures of $394K exceeded it, leaving free cash flow of −$15.5M.
Questions
What was Rapid Micro Biosystems' revenue in the first quarter 2026?
Rapid Micro Biosystems (RPID) reported revenue of $8.0M for the first quarter 2026 (Q1 2026), +11% from a year earlier and -29% from the quarter before.
Was Rapid Micro Biosystems profitable in the first quarter 2026?
Operating loss was $13.9M (-173.1% of revenue) and net loss $14.3M.